R
Regulus Therapeutics D
D
RGLS
8.10000
USD
0.01
(0.12%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-12
حجم السوق
560,796,121
الأخبار المقالات
العنوان: Regulus Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.